ArticleFrontiers in neurology
Critical role of accompanying authorized surrogates among the multifactorial determinants of in-hospital delays in patients with acute stroke.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the widespread establishment of stroke centers, delays in pre-hospital and in-hospital care persist. To date, no studies have investigated the role of accompanying authorized surrogates in early emergency care timelines and the outcomes of acute stroke. This study aimed to analyze the influence of types of surrogate decision-maker on critical time intervals and early clinical outcomes. Methods: This retrospective cohort study was conducted in patients with acute stroke or those with suspected stroke admitted to a stroke center. The correlation between the type of accompanying authorized surrogate at patient admission and both early in-hospital emergency timelines [medical order, computed tomography (CT) imaging and emergency treatment times] and early prognosis (neurological outcome, incidence of adverse events) was analyzed using statistical methods, including univariate and multivariate regression analysis. Results: A total of 508 patients were managed via the stroke fast-track; among these, 414 were diagnosed with acute stroke. The type of accompanying authorized surrogate significantly influenced all in-hospital treatment time metrics. Patients without a surrogate decision-maker experienced significantly longer orders, CT imaging, and emergency treatment times than those with a surrogate ( Conclusion: Early in-hospital delays in patients with acute stroke are multifactorial. The presence and type of accompanying authorized surrogates have a considerable effect on in-hospital emergency treatment time for acute stroke. However, the type of accompanying authorized surrogate showed a weak correlation with early prognosis in patients with acute stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.